Alsakali Equity AB — CEO
Roles
12.11.2025 – 18.11.2025
Transactions (including via associated entities)
| Date | Issuer | Nature | Volume | Price | Value | Source |
|---|---|---|---|---|---|---|
| 18.11.2025 | Newbury Pharmaceuticals AB Stockholm | Bought — open marketAcquisition | 25,859 | SEK 1.59 | SEK 41,115.81 | ↗ |
| 17.11.2025 | Newbury Pharmaceuticals AB Stockholm | Bought — open marketAcquisition | 67,855 | SEK 1.39 | SEK 94,318.45 | ↗ |
| 12.11.2025 | Newbury Pharmaceuticals AB Stockholm | Bought — open marketAcquisition | 20,000 | SEK 1.91 | SEK 38,172.00 | ↗ |